Bongiovanni Massimo, Spitale Alessandra, Faquin William C, Mazzucchelli Luca, Baloch Zubair W
Institute of Pathology, Locarno, Switzerland.
Acta Cytol. 2012;56(4):333-9. doi: 10.1159/000339959. Epub 2012 Jul 25.
We aimed to investigate the validity of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) through meta-analysis.
All publications between January 1, 2008 and September 1, 2011 that studied TBSRTC and had available histological follow-up data were retrieved. To calculate the sensitivity, specificity and diagnostic accuracy, the cases diagnosed as follicular neoplasm, suspicious for malignancy and malignant which were histopathologically confirmed as malignant were defined as true-positive. True-negative included benign cases confirmed as benign on histopathology. The nondiagnostic category was excluded from the statistical calculation. The correlations between the 6 diagnostic categories were investigated.
The publications review resulted in a case cohort of 25,445 thyroid fine-needle aspirations, 6,362 (25%) of which underwent surgical excision; this group constituted the basis of the study. The sensitivity, specificity and diagnostic accuracy were 97, 50.7 and 68.8%, respectively. The positive predictive value and negative predictive value were 55.9 and 96.3%, respectively. The rates of false negatives and false positives were low: 3 and 0.5%, respectively.
The results of meta-analysis showed high overall accuracy, indicating that TBSRTC represents a reliable and valid reporting system for thyroid cytology.
我们旨在通过荟萃分析研究甲状腺细胞病理学报告贝塞斯达系统(TBSRTC)的有效性。
检索2008年1月1日至2011年9月1日期间所有研究TBSRTC且有可用组织学随访数据的出版物。为计算敏感性、特异性和诊断准确性,将组织病理学确诊为恶性的诊断为滤泡性肿瘤、可疑恶性和恶性的病例定义为真阳性。真阴性包括组织病理学确诊为良性的良性病例。非诊断类别被排除在统计计算之外。研究了6种诊断类别的相关性。
文献综述产生了一个包含25445例甲状腺细针穿刺的病例队列,其中6362例(25%)接受了手术切除;该组构成了研究基础。敏感性、特异性和诊断准确性分别为97%、50.7%和68.8%。阳性预测值和阴性预测值分别为55.9%和96.3%。假阴性率和假阳性率较低:分别为3%和0.5%。
荟萃分析结果显示总体准确性较高,表明TBSRTC是一种可靠且有效的甲状腺细胞学报告系统。